AwardedPOLGoods
Sukcesywna dostawa leku (TYP 1) stosowanego w ramach programu lekowego NFZ (terapia WZW C) na potrzeby Wrocławskiego Centrum Zdrowia SP ZOZ.
- Published
- Published 19 March 2026
- Deadline
- Closed 20 April 2026
Overview
Wrocławskie Centrum Zdrowia awarded a contract to Urtica Sp. z o.o. on 2 June 2026 for the successive supply of antiviral medication (sofosbuvir 400mg and velpatasvir 100mg tablets) for hepatitis C treatment under an NFZ-funded programme, totalling 128 packages for 1,379,500.78 PLN. The medication is to be delivered during 2026 and partially in 2027 for the treatment of chronic hepatitis C infection in adults and adolescents aged 12 and over.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Published
- 19 March 2026
- Deadline
- Closed
Medicinal products for the alimentary tract and metabolism
Award outcome
- Awarded value
- PLN 1,379,501
- Award date
- 2 June 2026
- Contract period
- — → 28 May 2027
- Urtica Sp. z o.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
11 June 2026
Contract Notice
19 March 2026
Contracting authority
Wrocławskie Centrum Zdrowia Samodzielny Publiczny Zakład Opieki Zdrowotnej
Procuring entityWrocław, POL
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.